Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands... Show more
Emerson Electric Co. has completed a multi-year transformation into a focused automation and software company, divesting its Climate Technologies business while moving to full ownership of AspenTech, an industrial-software leader. This shift concentrates Emerson on high-value, mission-critical control systems, intelligent devices, and software that customers depend on to run plants safely and efficiently — a positioning reinforced by a substantial installed base and a recurring MRO (maintenance, repair, and operations) revenue stream.
The company's competitive moat rests on its "automation tech stack," which spans sensors, valves, and control systems through to optimization software. By layering AI (artificial intelligence) agents, virtual advisors, and grid-management tools onto that installed base, Emerson is targeting a mix shift toward higher-margin, recurring software revenue. Management has framed this through explicit 2028 goals: roughly $21 billion in net sales and a 30% adjusted segment EBITA margin (earnings before interest, taxes, and amortization). Achieving those targets would require sustained margin expansion of about 2.4 percentage points, driven by pricing, operational efficiency, and integration synergies.
The most immediate catalyst is Emerson's fiscal fourth-quarter 2026 earnings release, when investors will scrutinize the fiscal 2027 outlook against consensus expectations and the company's stated mid-term framework of 4–7% organic sales growth and 10% adjusted EPS (earnings per share) growth. Mizuho, which rates the stock Outperform with a $180 price target, expects fiscal third-quarter underlying orders up 7% and sales up 6%, with a backlog near $8.2 billion — conditions that would set a constructive tone into the new fiscal year.
Product and partnership momentum represents a second catalyst. Recent collaborations with Saudi Aramco on digital corrosion management and with SiMa.ai on machine-learning-enabled industrial PCs extend Emerson's AI and edge-analytics capabilities. New offerings such as the AspenTech AVA AI platform and Ovation Virtual Advisor are early but could accelerate software adoption if customer pilots convert to recurring contracts.
Analyst sentiment is broadly constructive but not uniform. S&P Global consensus data shows about 30 analysts with an overall "Buy" rating and an average price target near $175, ranging from roughly $104 to $205. Recent actions skew positive — Mizuho raised its target to $180, J.P. Morgan to $184, and RBC Capital and Bernstein each hold Buy ratings with targets of $188 and $186, respectively — while Morgan Stanley stands out as a contrarian with a maintained Sell rating and a $145 target. This dispersion suggests the debate hinges on whether software-led margin expansion outweighs cyclical and regional headwinds.
Emerson's trajectory is tightly linked to the global energy and industrial investment cycle. The power and electrification build-out — including grid modernization and data center expansion — has driven exceptionally strong order growth in its power-related businesses, with orders up roughly 30% in fiscal 2025. LNG, life sciences, and semiconductor markets add further secular support.
On the macro side, interest rates and inflation shape both Emerson's project-based backlog and its cost structure. Management expects price realization to remain a durable margin lever, while FX volatility, tariffs, and sluggish European and Chinese demand act as offsetting pressures. The company has also flagged a roughly $25 million quarterly headwind from Middle East exposure, illustrating the geopolitical sensitivity of its international footprint. Because a large share of revenue comes from outside the United States, currency movements and trade policy will remain important swing factors.
For traders seeking a data-driven read on where a stock may be headed next, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool designed to identify whether an asset such as a stock or ETF is likely to trend bullish, bearish, or sideways over the coming week or month. The tool helps users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, with searchable prediction categories, historical context, and alert-oriented functionality. Whether you are monitoring Emerson or other names, the Trend Prediction Engine can complement your own research as you assess potential setups.
Looking toward 2026 and beyond, Emerson's story centers on whether its software and AI ambitions translate into durable, higher-margin revenue. The company's 2028 framework targets roughly $21 billion in net sales, a 30% adjusted segment EBITA margin, $8 in adjusted EPS, and $12 billion in cumulative free cash flow (FCF) — with about $10 billion planned for shareholder returns through dividends and buybacks. These figures imply a disciplined capital-allocation strategy aimed at both growth and shareholder value.
Several long-term themes deserve monitoring. First, the shift toward software-defined automation and AI-enabled asset management could expand Emerson's addressable market and lengthen revenue duration through multi-year service contracts. Second, margin sustainability will depend on pricing power, footprint optimization, and the successful integration of AspenTech and the Test & Measurement franchise, where semiconductor and defense demand is currently strong. Third, competitive threats from larger automation peers and emerging AI-native entrants could pressure Emerson's premium positioning. Finally, regulatory and trade developments — including tariff policy and energy-transition incentives — may reshape end-market demand. Consensus expectations remain anchored to mid-single-digit growth and gradual margin expansion, but the wide gap between the most bullish and most cautious analyst projections underscores that execution, not just opportunity, will determine the next leg of the stock's trajectory.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, EMR has been closely correlated with AME. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then AME could also see price increases.
| Ticker / NAME | Correlation To EMR | 1D Price Change % |
|---|---|---|
| EMR | 100% | +2.83% |
| EMR (5 stocks) | 81% Closely correlated | +0.61% |
| Producer Manufacturing (347 stocks) | 14% Poorly correlated | +0.63% |
a developer of process controls systems, valves and analytical instruments
Industry IndustrialMachinery
The Moving Average Convergence Divergence (MACD) for EMR turned positive on October 27, 2026. Looking at past instances where EMR's MACD turned positive, the stock continued to rise in 31 of 44 cases over the following month. The odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on EMR as a result. In 58 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
The 10-day moving average for EMR crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in 216 of 344 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 160 of 274 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
EMR broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 27 (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.551) is normal, around the industry mean (3.957). P/E Ratio (36.224) is within average values for comparable stocks, (38.190). Projected Growth (PEG Ratio) (1.837) is also within normal values, averaging (1.879). Dividend Yield (0.013) settles around the average of (0.030) among similar stocks. P/S Ratio (4.409) is also within normal values, averaging (186.943).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.